APP and Alzheimer disease: These upstream regulators are involved in the pathogenesis and molecular alterations present in AD in different manners such as through the formation of amyloid/senile plaques (APP and PSEN1) and the development of neurofibrillary tangles (MAPT/Tau, PSEN1) [77,78,79].